PXS Stock Overview
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Paragon Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.29 |
| 52 Week High | AU$0.29 |
| 52 Week Low | AU$0.22 |
| Beta | 0 |
| 11 Month Change | 11.45% |
| 3 Month Change | 8.15% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 32.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| PXS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 5.0% | -0.3% | -0.4% |
| 1Y | n/a | 14.5% | 7.1% |
Return vs Industry: Insufficient data to determine how PXS performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how PXS performed against the German Market.
Price Volatility
| PXS volatility | |
|---|---|
| PXS Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PXS's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PXS's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 550 | David Collins | www.paragoncare.com.au |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. It operates through two segments: ParagonCare and CH2. The company offers its for aesthetics, controlle, critical care, diagnostic and scientific, eye care, medical products and consumables, neonatal, orthopaedics service, surgical, technology & connectivity, urology, and veterinary products.
Paragon Care Limited Fundamentals Summary
| PXS fundamental statistics | |
|---|---|
| Market cap | €514.32m |
| Earnings (TTM) | €5.21m |
| Revenue (TTM) | €1.85b |
98.8x
P/E Ratio0.3x
P/S RatioIs PXS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PXS income statement (TTM) | |
|---|---|
| Revenue | AU$2.97b |
| Cost of Revenue | AU$2.79b |
| Gross Profit | AU$176.07m |
| Other Expenses | AU$167.69m |
| Earnings | AU$8.38m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0051 |
| Gross Margin | 5.93% |
| Net Profit Margin | 0.28% |
| Debt/Equity Ratio | 62.7% |
How did PXS perform over the long term?
See historical performance and comparison